Synergistic Opportunities in the Interplay Between Cancer Screening and Cardiovascular Disease Risk Assessment

Catherine E. Handy, Renato Quispe, Xavier Pinto, Michael Blaha, Roger S Blumenthal, Erin Donnelly Michos, Joao Lima, Eliseo Guallar, Seungho Ryu, Juhee Cho, James A. Kaye, Josep Comin-Colet, Xavier Corbella, Miguel Cainzos-Achirica

Research output: Contribution to journalArticle

Abstract

Cardiovascular disease (CVD) and cancer continue to be the 2 leading causes of death in developed countries despite significant improvements in the prevention, screening, and treatment of both diseases. They remain significant public health problems, growing in importance globally. Despite this threat, the fields of cardiology and oncology have been relatively disconnected. With many shared modifiable risk factors, cancer and CVD often coexist in the same individuals; those diagnosed with lung cancer, breast cancer, and colon cancer are at higher risk of CVD, and those with CVD are at higher risk of developing many types of common cancers. Screening paradigms have been established in parallel, but there are opportunities for combined risk assessments for cancer and CVD risk. Joining forces for combined cardiovascular and hemato-oncological preventive and research efforts will likely have synergistic, worldwide public health benefits.

Original languageEnglish (US)
Pages (from-to)727-734
Number of pages8
JournalCirculation
Volume138
Issue number7
DOIs
StatePublished - Aug 14 2018

Fingerprint

Early Detection of Cancer
Cardiovascular Diseases
Colonic Neoplasms
Neoplasms
Public Health
Breast Neoplasms
Insurance Benefits
Cardiology
Developed Countries
Cause of Death
Lung Neoplasms
Research

Keywords

  • cancer
  • cardiovascular diseases
  • prevention
  • screening

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Synergistic Opportunities in the Interplay Between Cancer Screening and Cardiovascular Disease Risk Assessment. / Handy, Catherine E.; Quispe, Renato; Pinto, Xavier; Blaha, Michael; Blumenthal, Roger S; Michos, Erin Donnelly; Lima, Joao; Guallar, Eliseo; Ryu, Seungho; Cho, Juhee; Kaye, James A.; Comin-Colet, Josep; Corbella, Xavier; Cainzos-Achirica, Miguel.

In: Circulation, Vol. 138, No. 7, 14.08.2018, p. 727-734.

Research output: Contribution to journalArticle

Handy, Catherine E. ; Quispe, Renato ; Pinto, Xavier ; Blaha, Michael ; Blumenthal, Roger S ; Michos, Erin Donnelly ; Lima, Joao ; Guallar, Eliseo ; Ryu, Seungho ; Cho, Juhee ; Kaye, James A. ; Comin-Colet, Josep ; Corbella, Xavier ; Cainzos-Achirica, Miguel. / Synergistic Opportunities in the Interplay Between Cancer Screening and Cardiovascular Disease Risk Assessment. In: Circulation. 2018 ; Vol. 138, No. 7. pp. 727-734.
@article{1c502e25bf0b42a9a031b089e4f0b490,
title = "Synergistic Opportunities in the Interplay Between Cancer Screening and Cardiovascular Disease Risk Assessment",
abstract = "Cardiovascular disease (CVD) and cancer continue to be the 2 leading causes of death in developed countries despite significant improvements in the prevention, screening, and treatment of both diseases. They remain significant public health problems, growing in importance globally. Despite this threat, the fields of cardiology and oncology have been relatively disconnected. With many shared modifiable risk factors, cancer and CVD often coexist in the same individuals; those diagnosed with lung cancer, breast cancer, and colon cancer are at higher risk of CVD, and those with CVD are at higher risk of developing many types of common cancers. Screening paradigms have been established in parallel, but there are opportunities for combined risk assessments for cancer and CVD risk. Joining forces for combined cardiovascular and hemato-oncological preventive and research efforts will likely have synergistic, worldwide public health benefits.",
keywords = "cancer, cardiovascular diseases, prevention, screening",
author = "Handy, {Catherine E.} and Renato Quispe and Xavier Pinto and Michael Blaha and Blumenthal, {Roger S} and Michos, {Erin Donnelly} and Joao Lima and Eliseo Guallar and Seungho Ryu and Juhee Cho and Kaye, {James A.} and Josep Comin-Colet and Xavier Corbella and Miguel Cainzos-Achirica",
year = "2018",
month = "8",
day = "14",
doi = "10.1161/CIRCULATIONAHA.118.035516",
language = "English (US)",
volume = "138",
pages = "727--734",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Synergistic Opportunities in the Interplay Between Cancer Screening and Cardiovascular Disease Risk Assessment

AU - Handy, Catherine E.

AU - Quispe, Renato

AU - Pinto, Xavier

AU - Blaha, Michael

AU - Blumenthal, Roger S

AU - Michos, Erin Donnelly

AU - Lima, Joao

AU - Guallar, Eliseo

AU - Ryu, Seungho

AU - Cho, Juhee

AU - Kaye, James A.

AU - Comin-Colet, Josep

AU - Corbella, Xavier

AU - Cainzos-Achirica, Miguel

PY - 2018/8/14

Y1 - 2018/8/14

N2 - Cardiovascular disease (CVD) and cancer continue to be the 2 leading causes of death in developed countries despite significant improvements in the prevention, screening, and treatment of both diseases. They remain significant public health problems, growing in importance globally. Despite this threat, the fields of cardiology and oncology have been relatively disconnected. With many shared modifiable risk factors, cancer and CVD often coexist in the same individuals; those diagnosed with lung cancer, breast cancer, and colon cancer are at higher risk of CVD, and those with CVD are at higher risk of developing many types of common cancers. Screening paradigms have been established in parallel, but there are opportunities for combined risk assessments for cancer and CVD risk. Joining forces for combined cardiovascular and hemato-oncological preventive and research efforts will likely have synergistic, worldwide public health benefits.

AB - Cardiovascular disease (CVD) and cancer continue to be the 2 leading causes of death in developed countries despite significant improvements in the prevention, screening, and treatment of both diseases. They remain significant public health problems, growing in importance globally. Despite this threat, the fields of cardiology and oncology have been relatively disconnected. With many shared modifiable risk factors, cancer and CVD often coexist in the same individuals; those diagnosed with lung cancer, breast cancer, and colon cancer are at higher risk of CVD, and those with CVD are at higher risk of developing many types of common cancers. Screening paradigms have been established in parallel, but there are opportunities for combined risk assessments for cancer and CVD risk. Joining forces for combined cardiovascular and hemato-oncological preventive and research efforts will likely have synergistic, worldwide public health benefits.

KW - cancer

KW - cardiovascular diseases

KW - prevention

KW - screening

UR - http://www.scopus.com/inward/record.url?scp=85055647713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055647713&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.118.035516

DO - 10.1161/CIRCULATIONAHA.118.035516

M3 - Article

VL - 138

SP - 727

EP - 734

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 7

ER -